Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The Cost of Patients With Relapsing-Remitting Multiple Sclerosis Who Develop Neutralizing Antibodies While Treated With Interferon Beta.
Fampridine-PR (prolonged released 4-aminopyridine) is not effective in patients with inflammatory demyelination of the peripheral nervous system.
Modulation of the immune system by UV radiation: more than just the effects of vitamin D?
Dichoptic Metacontrast Masking Functions to Infer Transmission Delay in Optic Neuritis.
Clinical Overlap of Multiple Sclerosis and Autoimmune Hepatitis: Three Cases.
Autologous hematopoietic stem cell transplantation in multiple sclerosis: 20 years of experience.
Exclusive expression of the Rab11 effector SH3TC2 in Schwann cells links integrin-α6 and myelin maintenance to Charcot-Marie-Tooth disease type 4C.
Mediterranean diet adherence and risk of multiple sclerosis: a case-control study.
Pemetrexed-Induced Nephrogenic Diabetes Insipidus.
Combined brain and anterior visual pathways' MRIs assist in early identification of neuromyelitis optica spectrum disorder at onset of optic neuritis.
Safety of Striatal Infusion of siRNA in a Transgenic Huntington's Disease Mouse Model.
Health Care Resource Utilization Associated with Pediatric Patients Diagnosed with Relapsing Remitting Multiple Sclerosis.
A case-control study of risk factors for multiple sclerosis in Iran.
Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?
Modulation of neuronal activity by the endogenous pentapeptide QYNAD.
A Novel Combination of Docosahexaenoic Acid, All-Trans Retinoic Acid, and 1, 25-Dihydroxyvitamin D3 Reduces T-Bet Gene Expression, Serum Interferon Gamma, and Clinical Scores but Promotes PPARγ Gene Expression in Experimental Autoimmune Encephalomyelitis
Interim Report Released on Real-World Safety of Fingolimod for Relapsing MS
Accelerated longitudinal gray/white matter contrast decline in aging in lightly myelinated cortical regions.
Subcortical White Matter Changes with Normal Aging Detected by Multi-Shot High Resolution Diffusion Tensor Imaging.
An Association Between Glatiramer Acetate and Malignant Melanoma.
Cytokine-induced release of ceramide-enriched exosomes as a mediator of cell death signaling in an oligodendroglioma cell line.
Immunomodulatory Effects Mediated by Dopamine.
Multiple sclerosis in Isfahan, Iran.
Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndrome.
Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients.
Pages
« first
‹ previous
…
729
730
731
732
733
734
735
736
737
…
next ›
last »